✦ LIBER ✦

Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study

✍ Scribed by Charalampos I. Mitsonis; Nikolaos P. Dimopoulos; Panagiotis A. Mitropoulos; Evangelia G. Kararizou; Alexandra N. Katsa; Fivos E. Tsakiris; Maria Nefeli E. Katsanou

Book ID: 116840889
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 173 KB
Volume: 31
Category: Article
ISSN: 0278-5846
DOI: 10.1016/j.pnpbp.2006.09.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open label pilot study to evaluate th

An open label pilot study to evaluate the efficacy of lymphoblastoid interferon (L-IFN) in patient with chronic hepatitis C previously treated with recombinant alpha-interferon (R-IFN)

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 168 KB

The impact of ω-3 fatty acids, vitamins

The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: An open-label pilot study

✍ E.Y. Sivrioglu; S. Kirli; D. Sipahioglu; B. Gursoy; E. Sarandöl 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 243 KB